Results 11 to 20 of about 24,988 (216)

Natural occurence of a biopolymer, poly (adenosine diphosphate ribose)

open access: yesNucleic Acids Research, 1977
Evidence for the natural occurrence of poly(adenosine diphosphate ribose) in vivo was obtained using a sensitive radioimmunoassay and poly(adenosine diphosphate ribose) glycohydrolase, which specifically hydrolyzes poly(adenosine diphosphate ribose).
H, Sakura   +6 more
openaire   +5 more sources

A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors. [PDF]

open access: yesCA Cancer J Clin
Hage Chehade C   +10 more
europepmc   +2 more sources

Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models. [PDF]

open access: yesCancer, 2020
Santiago-O'Farrill JM   +17 more
europepmc   +2 more sources

Structure/function analysis of PARP-1 in oxidative and nitrosative stress-induced monomeric ADPR formation. [PDF]

open access: yesPLoS ONE, 2009
Poly adenosine diphosphate-ribose polymerase-1 (PARP-1) is a multifunctional enzyme that is involved in two major cellular responses to oxidative and nitrosative (O/N) stress: detection and response to DNA damage via formation of protein-bound poly ...
Ben Buelow   +3 more
doaj   +1 more source

The Critical Role of PARPs in Regulating Innate Immune Responses

open access: yesFrontiers in Immunology, 2021
Poly (adenosine diphosphate-ribose) polymerases (PARPs) are a family of proteins responsible for transferring ADP-ribose groups to target proteins to initiate the ADP-ribosylation, a highly conserved and fundamental post-translational modification in all
Huifang Zhu   +4 more
doaj   +1 more source

Olaparib-Induced Purpuric Drug Eruption in a Patient with Castration-Resistant Prostate Cancer

open access: yesCase Reports in Oncology, 2023
Olaparib is recently approved as an anti-tumor agent for several cancers, including castration-resistant prostate cancer, which inhibits poly (adenosine diphosphate-ribose) polymerase, a DNA repair factor.
Mana Sekine   +3 more
doaj   +1 more source

PARPs and ADP-Ribosylation in Chronic Inflammation: A Focus on Macrophages

open access: yesPathogens, 2023
Aberrant adenosine diphosphate-ribose (ADP)-ribosylation of proteins and nucleic acids is associated with multiple disease processes such as infections and chronic inflammatory diseases. The poly(ADP-ribose) polymerase (PARP)/ADP-ribosyltransferase (ART)
Diego V. Santinelli-Pestana   +3 more
doaj   +1 more source

First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis [PDF]

open access: yesJournal of Immunotherapy and Precision Oncology, 2021
Niraparib, an inhibitor of poly(adenosine diphosphate [ADP]-ribose) 1 and 2, has been shown to improve progression free survival in patients when used as maintenance treatment after first-line platinum-based chemotherapy in advanced stage (III to IV ...
Alistair McLaren   +3 more
doaj   +1 more source

The Antiviral Activities of Poly-ADP-Ribose Polymerases

open access: yesViruses, 2021
The poly-adenosine diphosphate (ADP)-ribose polymerases (PARPs) are responsible for ADP-ribosylation, a reversible post-translational modification involved in many cellular processes including DNA damage repair, chromatin remodeling, regulation of ...
Mathilde Malgras   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy